In Italy, BMS fined €2.3M on antitrust charges

A fight over colostomy bags sounds like fodder for a bad joke, but Bristol-Myers Squibb isn't laughing: Italy's antitrust ministry has fined the company €2.3 million for restricting price competition for the bags. The Italian government says Bristol-Myers colluded with its competitors Coloplast, Hollister, and B Braun Milano--which also were fined--to keep prices up.

- read this report

Suggested Articles

AstraZeneca and Brazil have expanded their deal for a possible COVID-19 vaccine, this time to the tune of $360 million.

Novavax expects to churn out enough vaccines in 2021 to meet U.S. demand; experts slam the medical and political risks of Russia's unproven vaccine.

Novavax will have billions of doses of COVID-19 vaccine capacity next year and could single-handedly meet U.S. demand, executives said.